nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—PDE4C—ganglion—retroperitoneal cancer	0.115	0.142	CbGeAlD
Oxtriphylline—HDAC2—Notch Signaling Pathway—RBPJL—retroperitoneal cancer	0.091	0.483	CbGpPWpGaD
Oxtriphylline—ADORA2A—ganglion—retroperitoneal cancer	0.0836	0.103	CbGeAlD
Oxtriphylline—ADORA1—ganglion—retroperitoneal cancer	0.0722	0.089	CbGeAlD
Oxtriphylline—PDE3B—adrenal gland—retroperitoneal cancer	0.034	0.0419	CbGeAlD
Oxtriphylline—SLC22A7—kidney—retroperitoneal cancer	0.0288	0.0354	CbGeAlD
Oxtriphylline—PDE4D—adrenal gland—retroperitoneal cancer	0.0284	0.035	CbGeAlD
Oxtriphylline—PDE3B—testis—retroperitoneal cancer	0.0281	0.0347	CbGeAlD
Oxtriphylline—PDE4A—adrenal gland—retroperitoneal cancer	0.0251	0.031	CbGeAlD
Oxtriphylline—ADORA1—kidney—retroperitoneal cancer	0.0251	0.0309	CbGeAlD
Oxtriphylline—HDAC2—kidney—retroperitoneal cancer	0.0248	0.0305	CbGeAlD
Oxtriphylline—PDE4D—testis—retroperitoneal cancer	0.0235	0.0289	CbGeAlD
Oxtriphylline—ADORA2A—adrenal gland—retroperitoneal cancer	0.0235	0.0289	CbGeAlD
Oxtriphylline—ADORA2B—testis—retroperitoneal cancer	0.0233	0.0287	CbGeAlD
Oxtriphylline—PDE3A—adrenal gland—retroperitoneal cancer	0.0208	0.0256	CbGeAlD
Oxtriphylline—PDE4A—testis—retroperitoneal cancer	0.0208	0.0256	CbGeAlD
Oxtriphylline—PDE3B—lymph node—retroperitoneal cancer	0.0204	0.0251	CbGeAlD
Oxtriphylline—HDAC2—adrenal gland—retroperitoneal cancer	0.02	0.0247	CbGeAlD
Oxtriphylline—ADORA2A—testis—retroperitoneal cancer	0.0194	0.0239	CbGeAlD
Oxtriphylline—SLC22A7—testis—retroperitoneal cancer	0.0192	0.0237	CbGeAlD
Oxtriphylline—PDE3A—testis—retroperitoneal cancer	0.0172	0.0212	CbGeAlD
Oxtriphylline—PDE4D—lymph node—retroperitoneal cancer	0.017	0.021	CbGeAlD
Oxtriphylline—ADORA1—testis—retroperitoneal cancer	0.0168	0.0206	CbGeAlD
Oxtriphylline—HDAC2—testis—retroperitoneal cancer	0.0165	0.0204	CbGeAlD
Oxtriphylline—HDAC2—p75 NTR receptor-mediated signalling—ABR—retroperitoneal cancer	0.0164	0.0868	CbGpPWpGaD
Oxtriphylline—PDE4A—lymph node—retroperitoneal cancer	0.0151	0.0186	CbGeAlD
Oxtriphylline—PDE4B—adrenal gland—retroperitoneal cancer	0.015	0.0185	CbGeAlD
Oxtriphylline—PDE3A—lymph node—retroperitoneal cancer	0.0125	0.0154	CbGeAlD
Oxtriphylline—PDE4B—testis—retroperitoneal cancer	0.0124	0.0153	CbGeAlD
Oxtriphylline—ADORA1—lymph node—retroperitoneal cancer	0.0121	0.015	CbGeAlD
Oxtriphylline—HDAC2—lymph node—retroperitoneal cancer	0.012	0.0148	CbGeAlD
Oxtriphylline—PDE4B—lymph node—retroperitoneal cancer	0.00898	0.0111	CbGeAlD
Oxtriphylline—HDAC2—Signaling by NGF—ABR—retroperitoneal cancer	0.00602	0.032	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—ABR—retroperitoneal cancer	0.0056	0.0297	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—ABR—retroperitoneal cancer	0.00374	0.0199	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—ABR—retroperitoneal cancer	0.00341	0.0181	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—ABR—retroperitoneal cancer	0.0034	0.018	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—ABR—retroperitoneal cancer	0.00331	0.0176	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—ABR—retroperitoneal cancer	0.00326	0.0173	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—ABR—retroperitoneal cancer	0.0031	0.0165	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—ABR—retroperitoneal cancer	0.0031	0.0165	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—ABR—retroperitoneal cancer	0.00302	0.016	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—ABR—retroperitoneal cancer	0.00301	0.016	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—ABR—retroperitoneal cancer	0.00296	0.0157	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—ABR—retroperitoneal cancer	0.0029	0.0154	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—ABR—retroperitoneal cancer	0.00287	0.0152	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—ABR—retroperitoneal cancer	0.00282	0.0149	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—ABR—retroperitoneal cancer	0.00274	0.0145	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—ABR—retroperitoneal cancer	0.00264	0.014	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—ABR—retroperitoneal cancer	0.00261	0.0138	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—ABR—retroperitoneal cancer	0.00224	0.0119	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—ABR—retroperitoneal cancer	0.00204	0.0108	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—ABR—retroperitoneal cancer	0.00201	0.0107	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—ABR—retroperitoneal cancer	0.00183	0.00972	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—ABR—retroperitoneal cancer	0.00178	0.00943	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—ABR—retroperitoneal cancer	0.00175	0.00927	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—ABR—retroperitoneal cancer	0.00166	0.00883	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—ABR—retroperitoneal cancer	0.00162	0.00859	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—ABR—retroperitoneal cancer	0.00156	0.00827	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—ABR—retroperitoneal cancer	0.00154	0.00817	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—ABR—retroperitoneal cancer	0.00129	0.00687	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—ABR—retroperitoneal cancer	0.0012	0.00638	CbGpPWpGaD
